Initial Collaborative Practice Agreement Certificate Program

Successful completion of the Self-Study requires completing each corresponding lecture assessment for modules 1-4 with a 70% or higher. Assessment details are provided above and before each assessment.

Continuing pharmacy education credit is reported at the time of course completion. Partial credit will not be provided. Only participants who complete all three components of the program (Self-Study, 8.0-hour Live Seminar, and Live Seminar Assessment) will be awarded continuing pharmacy education credit.

Summary

This module will describe patient care in the ambulatory setting, components of collaborative practice agreements, and associated legal and professional practice requirements in the state of Florida. 

To Do

1. Watch Lecture 1.1-1.3.
2. Complete each corresponding Assessment.
3. Review the Required Reading.
4. Review the Supplemental Reading.
   

Slides

• Lecture 1.1: Patient Care in the Ambulatory Setting
• Lecture 1.2: Collaborative Practice Agreements
• Lecture 1.3: Collaborative Practice in the State of Florida (Part 1 (1-2); Part 2(1-3))
  

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

 Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Define ambulatory care as it pertains to pharmacists.
2. Identify common areas of practice and disease states encountered.
   
3. Describe the benefits of including pharmacists into ambulatory care teams.
   
4. Identify barriers facing ambulatory care pharmacists.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

 Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Define collaborative practice agreement (CPA).
2. Describe the benefits of practicing under a CPA.
3. Identify potential drawbacks of a CPA.
4. Identify potential barriers to implementation of a CPA.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Gary Cacciatore Pharm.D., J.D.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Define a pharmacist collaborative practice agreement as outlined in Chapter 64B16-31.005.
2. Review requirements outlined by Chapter 465 for a pharmacist to enter into a Collaborative Practice Agreement.
3. Review mandatory continuing education requirements required by the Florida Board of Pharmacy for pharmacists to enter into a Collaborative Practice Agreement.
4. Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a Collaborative Practice Agreement.

Presentation

Please allow up to 30 seconds for the video to load.

Speakers

Rachel E Shaddock Pharm.D.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a Collaborative Practice Agreement.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Florida Statutes

Section 465.1865, Florida Statutes

Florida Administrative Code

Rule Chapter: 64B16-31, Florida Administrative Code

Pharmacist Collaborative Practice Certification

Pharmacist Collaborative Practice Certification, Florida Board of Pharmacy

Patient Care in the Ambulatory Setting

CDC - Advancing Team-Based Care Through Collaborative Practice Agreements

Summary

This module will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:

1. Hyperlipidemia
2. Hypertension
3. Obesity
4. Anticoagulation
5. Nicotine Dependence

To Do

1. Watch Lecture 2.1-2.5.
2. Complete each corresponding Assessment.
3. Review the Supplemental Reading.

Slides

• Lecture 2.1: Hyperlipidemia
• Lecture 2.2: Hypertension
• Lecture 2.3: Obesity
• Lecture 2.4: Anticoagulation
• Lecture 2.5: Nicotine Dependence

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

 Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessments.
2. Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioner.
3. Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Rachel E Shaddock Pharm.D.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessment for a patient with hypertension.
2. Order, perform, and interpret clinical and laboratory testing for a patient with hypertension related to collaborative pharmacy practice.
3. Evaluate and manage hypertension, including drug therapy changes, in collaboration with other health care providers.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Carol A Motycka Pharm.D., CHSE

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Assess a patient to determine if they are a candidate for pharmacotherapy treatment of obesity based on BMI and other risk factors.
2. Recommend treatment options for obesity in both children and adults based on patient’s medical history, lab results, and other factors.
3. Evaluate and manage a patient’s treatment for obesity through appropriate drug therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Katherine Vogel Anderson Pharm.D., BCACP, FCCP

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessments for patient anticoagulation therapy.
2. Order, perform, and interpret clinical and laboratory testing for patient anticoagulation therapy related to collaborative pharmacy practice.
3. Evaluate and manage anticoagulation therapy, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Teresa E Roane Pharm.D., MBA, BCACP

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Discuss nicotine dependence and associated consequences from nicotine use.
2. Perform patient assessments regarding nicotine use.
3. Utilize motivational interviewing techniques to guide conversations regarding nicotine dependence.
4. Order, perform, and interpret clinical and laboratory tests specific to nicotine use related to collaborative practice in pharmacy.
5. Evaluate and manage nicotine dependence, including treatment options and medication therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Hyperlipidemia

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults

Nicotine Dependence

Clinical Cessation Tools - Centers for Disease Control and Prevention

Instrument: Fagerstrom Test For Nicotine Dependence (FTND)

Summary

This module will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:

1. Type 2 Diabetes Mellitus
2. Asthma
3. COPD
4. HIV
5. Arthritis
6. Substance Use Disorders and Opioid Reversal
7. Hepatitis C

To Do

1. Watch Lecture 3.1-3.7.
2. Complete each corresponding Assessment.
3. Review the Required Reading.
4. Review the Supplemental Reading.

Slides

• Lecture 3.1: Type 2 Diabetes Mellitus
• Lecture 3.2: Asthma
• Lecture 3.3: COPD
• Lecture 3.4: HIV
• Lecture 3.5: Arthritis
• Lecture 3.6: Substance Use Disorders and Opioid Reversal
• Lecture 3.7: Hepatitis C

Speakers

Lihui Yuan Pharm.D., Ph.D., R.Ph.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessments for patients with Type 2 Diabetes Mellitus (T2DM).
2. Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice for patients with T2DM.
3. Evaluate and manage T2DM, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Tracy E Leonard R.Ph., BCPP, BCACP,CDCES, C.Ph.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Assess current asthma control.
2. Order and evaluate spirometry.
3. Make changes in drug therapy, if appropriate.
4. Determine if biological therapy is indicated.

Presentation & Assessment

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Please allow up to 30 seconds for the video to load.

Please allow up to 30 seconds for the video to load.

Please allow up to 30 seconds for the video to load.

Speakers

Tracy E Leonard R.Ph., BCPP, BCACP,CDCES, C.Ph.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessments for patients with Chronic Obstructive Pulmonary Disease (COPD).
2. Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice for patients with COPD.
3. Evaluate and manage COPD, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Eric F Egelund Ph.D., Pharm.D.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessments for patients with HIV.
2. Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice for patients with HIV.
3. Evaluate and manage HIV, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Rachel E Shaddock Pharm.D.

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Perform patient assessment for a patient with arthritis.
2. Order, perform, and interpret clinical and laboratory testing for a patient with arthritis related to collaborative pharmacy practice.
3. Evaluate and manage arthritis, including drug therapy changes, in collaboration with other health care providers.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Carol A Motycka Pharm.D., CHSE

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Recognize how substance use disorders (SUD)/addiction are defined and the potential causes of these disorders.
2. Understand the impact substance use disorders have on the individual and on society.
3. Describe Best Practices in regards to screening and treatment of SUD.
4. Discuss how and when to use Naloxone in a patient who has overdosed.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Lindsey Childs-Kean Pharm.D., M.P.H., BCPS, FASHP

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Identify potential complications associated with Hepatitis C.
2. Analyze a patient to determine if they are a candidate for pharmacotherapy treatment of Hepatitis C.
3. Recommend treatment options for Hepatitis C in both children and adults and discuss the risks and benefits of each treatment.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Asthma

How to Use a Metered-Dose Inhaler, National Heart, Lung, and Blood Institute

How to Use a Nebulizer, National Heart, Lung, and Blood Institute

COPD

Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report

Summary

This module will discuss how to write a collaborative practice agreement and how to build a business model and marketing plan for your practice. 

To Do

1. Watch Lectures 4.1-4.4.
2. Complete the Self-Study Assessment.

Slides

• Lecture 4.1: Entering into Successful Collaborations with Other Providers
• Lecture 4.2: Documentation and Communication Strategies for Collaborative Practice
• Lecture 4.3: Building a Business Model for Collaborative Practice
• Lecture 4.4: Billing and Reimbursement

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

 Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Identify prescribers to collaborate within the development of a CPA.
2. Discuss the relationship with a prescriber.
3. Outline required elements of a CPA and communications, documentation, and other pertinent subjects related to a CPA.
4. Identify ways to secure and strengthen practitioner and patient relationships.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

 Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Summarize Florida law and other related requirements for documenting and maintaining documentation of collaborative practice activities.
2. Summarize Florida law and other related requirements for communicating with patients and providers in a collaborative practice agreement.
3. Identify strategies or systems to support efficient documentation and communication with patients and providers.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Teresa E Roane Pharm.D., MBA, BCACP

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Explain the purpose of a business plan.
2. List the core components of a typical business plan.
3. Review successful business models for collaborative practice.
4. Identify your competitive advantages.
5. Create a marketing strategy and elevator speech for your collaborative practice.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 3 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Speakers

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Lecture Objectives

Upon completion of this lecture, you should be able to:

1. Highlight a few common billing codes and their general requirements.
2. Communicate with coding and billing personnel in a shared language.
3. Identify appropriate billing-based resources.

Presentation

Please allow up to 30 seconds for the video to load.

After reviewing the lecture, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 2 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.

Live Seminar Completion Requirements

Successful completion of the live seminar component of the program requires attending the full live seminar (hosted virtually, via Zoom) and passing a live seminar assessment with a grade of 70% or higher. Successful completion of the live seminar assessment will result in 8.0 contact hours of live continuing pharmacy education credit.

Live Seminar Packet

Please see the live session materials below. You are not required to have these materials printed, but you must have access to the materials during the live session.

Zoom Meeting Etiquette

While this live session will be held virtually via Zoom, it is expected that learners will conduct themselves as they would should this session have been held in a physical classroom. We ask that learners please observe the guidelines below:

1. All participants must remain on camera for the duration of the session.
   • It is the responsibility of the participant to ensure he/she has a working camera and speakers to meet this requirement.
   • Exceptions to this include, but are not limited to:
     • Restroom breaks
     • Water breaks
     • Scheduled lunch break (or other breaks announced by the course facilitators)
     • Nursing/Breastfeeding
     • We ask that you please use the chat feature to notify either one or both of the session facilitators before stepping away.
2. All participants must show active participation for the duration of the session.
   • Participants are expected to actively participate through polling questions, chat messaging, and breakout rooms.
   • The following activities are not permitted during the live session; Engaging in any of the following may result in removal from the live session:
     • Sleeping
     • Driving
     • Shopping
     • Pointing webcam anywhere other than your face (i.e., ceiling, wall)
     • Please note that this is not an exhaustive list. We ask that you refrain from any behaviors that may be distracting to fellow learners.
3. For attendance purposes, your Zoom display name must match the name you registered for the course under.
   • To change your name after entering a Zoom meeting, click on the “Participants” button at the top of the Zoom window. Next, hover your mouse over your name in the “Participants” list on the right side of the Zoom window and click “Rename”. Enter the name you’d like to appear in the Zoom meeting and click on “OK".

Zoom Meeting Information

Information:

• Meeting Date: Your live session date is selected at the time of registration.
  • If a scheduling conflict arises, you may transfer to a different live session date. To do so, please reach out to our office. No shows will NOT be transferred automatically.
    
• Start Time: 8:00 AM Eastern Daylight/Standard Time (Florida)
  
• End Time: 5:00 PM Eastern Daylight/Standard Time (Florida)
  
• Zoom Waiting Room Opens: 7:30 AM Eastern Daylight/Standard Time
  
  • You will be placed in the waiting room until the room is opened at 8:00 AM Eastern Daylight/Standard Time.

Please be sure to download and test Zoom prior to the live seminar. Our office is unable to provide technical support during the meeting.

• Download and Test Zoom
• Zoom Frequently Asked Questions
• Zoom – Audio and Visual Overview

Zoom Meeting Link (04/25/2026 Live Session)

Only registrants of the above live session date may access this meeting link.

Please locate the Zoom Meeting Link section for your registered live session date to access your meeting link.

Zoom Meeting Link (06/13/2026 Live Session)

Only registrants of the above live session date may access this meeting link.

Please locate the Zoom Meeting Link section for your registered live session date to access your meeting link.

After attending the live seminar and reviewing the handouts, complete the assessment. You must pass the assessment with a 70% or higher to receive credit for this course. This assessment consists of 25 multiple choice questions and is untimed. Questions are displayed one at time, you will not be able to review or change previous answers. Once you begin the assessment, you must complete it in one sitting. You will have three attempts to pass the assessment.